Michael Solomon, Ph.D., director of the Center for Consumer Research and professor of marketing, in USA Today on the relationship between the economy and Halloween spending. Tim Swift, Ph.D., assistant professor of management, interviewed with KYW/3CBS about the legacy of Apple Founder Steve Jobs. In a story that ran in Forbes, USA Today and ABC News, The Associated Press interviewed John Stanton, Ph.D., professor of food marketing, for a story about grocery store chains eliminating the self-checkout.

CAMBRIDGE, Mass.– (BUSINESS WIRE )-- InVivo Therapeutics (OTCBB: NVIV), a company focused on the development of groundbreaking technologies for the treatment of spinal cord injuries (SCI), today announced that Chief Science Officer Dr. Christopher Pritchard, Ph.D., has been selected as the 2011 recipient of the American Spinal Injury Association’s (ASIA) prestigious Apple Award. The award recognizes excellence in publishing in spinal cord injury research across the globe.

Frank Reynolds, CEO of InVivo Therapeutics, has been named to the Irish Small Business 50. The Irish Small Business 50 will honor the entrepreneurs and business leaders who form the very backbone of the American economy; the doers and risk-takers who have ensured that where businesses are being built and wealth created, there you will find the Irish.

Our nominees will be companies or individuals who have displayed entrepreneurial excellence and traditional Irish American can-do to make their enterprises stand-outs in their field.

"As a first generation Irish American, it gives me pride to see the entrepreneurial spirit of our community recognized," said Frank Reynolds, CEO of InVivo Therapeutics. "It is an honor to be named to the inaugural Irish Small Business 50 and to be acknowledged by 'the Echo' for what we have accomplished at InVivo Therapeutics. Our team works tirelessly each day toward bringing the promise of our groundbreaking new technologies to those who have suffered spinal cord injuries."

Also named to the Irish Small Business 50, IABCN member Steve Lenox of Lenox Consulting and William Fry.

CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Corporation ("InVivo Therapeutics"), a company focused on the development of groundbreaking technologies for the treatment of spinal cord injuries (SCI), today announced the successful completion of a reverse merger (the "Merger") with InVivo Therapeutics Holdings Corp. ("InVivo").